Overview
Armin Cornejo-Quispe practices practicing medicine in Brussels, Belgium.
His clinical expertise encompasses Cerebral Hypoxia, Sepsis, and Metabolic Acidosis.
He is actively involved in clinical research, co-authoring 13 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Armin A. Cornejo-Quispe
Is Armin A. Cornejo-Quispe a top-rated expert for Cerebral Hypoxia?
MediFind is an objective health platform that identifies experts based on real-world data. Armin A. Cornejo-Quispe is classified as an Experienced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Armin A. Cornejo-Quispe participate in research or clinical trials?
Yes. Armin A. Cornejo-Quispe has published 13 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Armin A. Cornejo-Quispe's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cerebral HypoxiaMr. Cornejo-Quispe isExperienced. Learn about Cerebral Hypoxia.
- Metabolic AcidosisMr. Cornejo-Quispe isExperienced. Learn about Metabolic Acidosis.
- SepsisMr. Cornejo-Quispe isExperienced. Learn about Sepsis.